These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16473115)

  • 21. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM; Kuller LH
    Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 Apr; 145(16):48-50. PubMed ID: 14606402
    [No Abstract]   [Full Text] [Related]  

  • 23. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 24. Statins and primary prevention: is all the evidence in?
    Rashid S; Francis GA
    Can J Cardiol; 2008 Apr; 24(4):301-3. PubMed ID: 18401471
    [No Abstract]   [Full Text] [Related]  

  • 25. [New statin introduction. With more power against hypercholesterolemia].
    MMW Fortschr Med; 2002 Dec; 144(50):64. PubMed ID: 14610873
    [No Abstract]   [Full Text] [Related]  

  • 26. Choice of lipid-regulating drugs.
    Med Lett Drugs Ther; 2001 May; 43(1105):43-8. PubMed ID: 11378632
    [No Abstract]   [Full Text] [Related]  

  • 27. [Coronary heart disease patient after myocardial infarct. Must LDL cholesterol now be reduced to 70 mg/dl?]].
    MMW Fortschr Med; 2005 Dec; 147(49-50):17-8. PubMed ID: 16401004
    [No Abstract]   [Full Text] [Related]  

  • 28. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract]   [Full Text] [Related]  

  • 29. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract]   [Full Text] [Related]  

  • 31. [New approaches in LDL cholesterol reduction].
    Füeßl HS
    MMW Fortschr Med; 2015 Jul; 157(13):39. PubMed ID: 26206031
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of more intensive lowering of LDL cholesterol.
    Bonovas S; Nikolopoulos G; Sitaras NM
    Lancet; 2011 Feb; 377(9767):715; author reply 715-6. PubMed ID: 21353894
    [No Abstract]   [Full Text] [Related]  

  • 33. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins: some women don't get the benefits.
    Consum Rep; 2010 Aug; 75(8):12. PubMed ID: 20648735
    [No Abstract]   [Full Text] [Related]  

  • 35. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):10-2. PubMed ID: 16455008
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?].
    Windler E
    Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 39. Ask the doctor. Taking a cholesterol-lowering statin has brought down my bad cholesterol (LDL) to only 37 mg/dL. My liver and muscles are fine. The very low LDL worries my doctor. Should I change my regimen?
    Lee TH
    Harv Heart Lett; 2002 Oct; 13(2):8. PubMed ID: 12393347
    [No Abstract]   [Full Text] [Related]  

  • 40. [Atorvastatin].
    Kajinami K; Takekoshi N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():598-604. PubMed ID: 11347138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.